Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease

被引:10
|
作者
Uno, Yoshiharu [1 ]
机构
[1] Off Uno Column, 419-2 Yota,Onoe Cho, Kakogawa, Hyogo, Japan
关键词
Inflammatory bowel disease; Irritable bowel syndrome; FODMAP; Mast cell; Ischemia; LOW-FODMAP DIET; IBS-LIKE SYMPTOMS; QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL SYMPTOMS; ILEAL CROHNS-DISEASE; ULCERATIVE-COLITIS; INTESTINAL PERMEABILITY; HYDROGEN-SULFIDE; BLOOD-FLOW; VISCERAL HYPERSENSITIVITY;
D O I
10.1016/j.mehy.2019.109324
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Functional bowel symptoms can be occurred during remission from inflammatory bowel disease. In this case, a low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet is effective for the amelioration or prevention of symptoms. However, the reason is not fully explained. This report proposes a hypothesis regarding the entire process in which inflammatory bowel disease with IBS-like symptoms (IBD-IBS) causes symptoms. A detailed process was assumed, starting from high pressure in the lumen and finally to abdominal symptoms. In this process, relationships were linked based on interactions such as ischemia, compliance, pain threshold, visceral hypersensitivity, mast cells, and permeability reported in IBD-IBS. In the process mapping, to understand the relationship between the amount of gas increased by FODMAP and ischemia, the hydrodynamic hypothesis and Ritchie's hypothesis were adapted. Ischemia in dilated intestines due to an increase in gas volume can induce excessive spasms via the mast cells and show the whole process of lowering the pain threshold. From the standpoint of the mechanism of IBD-IBS, the origin trigger may be FODMAP. Therefore, a low-FODMAP diet is recommended to relieve and prevent IBD-IBS symptoms.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Irritable Bowel Syndrome in Inflammatory Bowel Disease
    Ryu, Ki-Hyun
    Huh, Kyu-Chan
    [J]. INTESTINAL RESEARCH, 2010, 8 (02) : 95 - 105
  • [2] Inflammatory bowel disease and irritable bowel syndrome
    Kamp, K. J.
    Matthews, S. W.
    Heitkemper, M. M.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (04) : 730 - 731
  • [3] Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?
    Mearin, Fermin
    Perello, Antonia
    Balboa, Agustin
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2009, 32 (05): : 364 - 372
  • [4] Irritable bowel syndrome and inflammatory bowel disease in pregnancy
    Bruno, M
    [J]. JOURNAL OF PERINATAL & NEONATAL NURSING, 2004, 18 (04) : 341 - 350
  • [5] Volatomics in inflammatory bowel disease and irritable bowel syndrome
    Van Malderen, Kathleen
    De Winter, Benedicte Y.
    De Man, Joris G.
    De Schepper, Heiko U.
    Lamote, Kevin
    [J]. EBIOMEDICINE, 2020, 54
  • [6] Irritable bowel syndrome - the new inflammatory bowel disease?
    Spiller, Robin
    [J]. CLINICAL MEDICINE, 2008, 8 (04) : 417 - 419
  • [7] INFLAMMATORY BOWEL-DISEASE AND IRRITABLE BOWEL SYNDROME
    BAYLESS, TM
    HARRIS, ML
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1990, 74 (01) : 21 - 28
  • [8] Probiotics, irritable bowel syndrome, and inflammatory bowel disease
    Martin H. Floch
    [J]. Current Treatment Options in Gastroenterology, 2003, 6 (4) : 283 - 288
  • [9] Which is it: Irritable bowel syndrome or inflammatory bowel disease?
    Heitkemper, M
    [J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2001, 10 (04): : 394 - 394
  • [10] INFLAMMATORY BOWEL-DISEASE OR IRRITABLE BOWEL SYNDROME
    THOMPSON, WG
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1982, 127 (04) : 271 - 272